Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Location status: Recruiting
NCT Number: NCT02747888
Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules.
* In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies. * Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Location status: Recruiting
The purpose of this research study is to learn more about risk factors for inherited thyroid cancer.
The investigators would like to use the participant DNA to look for alterations in genes. The investigator will perform DNA sequencing and other genetic studies to identify errors in the genes that may contribute to the formation of thyroid nodules and cancer.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Contact information is provided by the study sponsor or research team.
Junne Kamihara, MD, PhD
CONTACT
Sarah Hunt, MPH
CONTACT
Dana-Farber Cancer Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07707401
Endocrine Gland Neoplasms, Endocrine System Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07600580
Endocrine Gland Neoplasms, Endocrine System Diseases
Zagreb, City of Zagreb, Croatia
View Trial DetailsNCT06738888
Endocrine Gland Neoplasms, Endocrine System Diseases
Shanghai, China
View Trial DetailsNCT06730321
Adenocarcinoma, Adenocarcinoma, Papillary
Shanghai, China
View Trial Details